Ginkgo Bioworks (DNA) announced the successful completion of their initial collaboration to develop and optimize a low-cost, efficient fermentation process for complex bacterial strains used as a component in one of Agricen’s soil amendment products.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Ginkgo Bioworks partners with Deep Origin to develop new drug safety tools
- Ginkgo Bioworks awarded four-year, up to $47M contract from EMSL
- Private Markets: Prediction market platform Kalshi secures $300M
- Private Markets: Anthropic to invest $50B in computing infrastructure
- Ginkgo Bioworks Earnings Call: Mixed Sentiments and Strategic Moves